Lee M Nadler

This inventor holds 31 USPTO granted patents. Top assignees: Dana-Farber-Cancer Institute Inc., Genetics Institute, Inc., Harvard College. Active years: 1987-2011.

USPTO Granted Patents = 31

% Patents Active = 64.5

Average Co-Inventor Count = 3.7

ph-index = 15

Forward Citations = 532(Granted Patents)

Company Filing History:

23 out of 1,265

Dana-Farber-Cancer Institute Inc.

patents

5 out of 392

Genetics Institute, Inc.

The Brigham and Women's Hospital, Inc.

National Institute of Health and Medical Research

patents

8. 1 out of 2,023

University System of Maryland

patents

9. 7 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1987-2011

Loading Chart...

Areas of Expertise:

Cancer Immunotherapy

Tumor Cells

Antigen-Presenting Cells

T Cell Proliferation

B7-1 Polypeptides

CD100 Antigen

Cytokine Receptor Manipulation

Fusion Proteins

CTLA-4 Specific Antibodies

B7-2 Molecules

Monoclonal Antibodies

Immunogenicity Enhancement

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8026224 - Tumor cells with increased immunogenicity and uses therfor (2011-09-27),

2. 7955845 - Modified antigen-presenting cells (2011-06-07),

3. 7851591 - Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT (2010-12-14),

4. 7700102 - Nucleic acids encoding CD100 molecules (2010-04-20),

5. 7619078 - Nucleic acid molecules encoding B7-1 (2009-11-17),

6. 7592007 - Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies (2009-09-22),

7. 7459544 - Nucleic acids encoding B7-2 fusion proteins (2008-12-02),

8. 7385023 - Cancer immunotherapy and diagnosis using cytochrome P450 1B1 (2008-06-10),

9. 7195758 - Methods of inducing a T cell mediated immune response by administering antigen presenting B cells (2007-03-27),

10. 7153934 - T cell costimulatory polypeptides containing alternative domains (2006-12-26),

11. 6824779 - Methods for inhibiting the interaction of B7-2 with its natural ligand (2004-11-30),

12. 6723705 - Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor (2004-04-20),

13. 6719972 - Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies (2004-04-13),

14. 6653444 - Polypeptides comprising a B7 extracellular domain (2003-11-25),

15. 6608180 - B7-specific antibodies (2003-08-19),

Title: The Innovative Mind of Lee M Nadler

Introduction: Lee M Nadler is a pioneering inventor based in Newton, MA, known for her groundbreaking contributions to the field of science and technology.

Latest Patents: Lee M Nadler holds several patents in the areas of biotechnology and medical research, focusing on novel treatments for various diseases.

Career Highlights: With a distinguished career spanning over three decades, Lee M Nadler has held key positions in renowned research institutions and biotech companies. Her work has significantly impacted the development of cutting-edge therapies.

Collaborations: Throughout her career, Lee M Nadler has collaborated with leading scientists, researchers, and medical professionals to further advance the boundaries of innovation in the healthcare industry.

Conclusion: Lee M Nadler's relentless pursuit of innovation and her passion for improving human health have solidified her reputation as a trailblazing inventor in the field of biotechnology.